Effect of combination of Thyme, Oregano, Echinacea and Mallow flowers on in treating common cold and influenza

Assessing the effect of combination of Thyme, Oregano, Echinacea and Mallow flowers on the severity of cold and influenza symptoms

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140804018677N19

Enrollment

Registered

2022-05-07

Start date

2022-05-04

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: common cold. Condition 2: Influenza. Acute nasopharyngitis [common cold] Influenza due to other identified influenza virus

Interventions

Intervention 1: Intervention group: 750 mg Rocoldup (Ghaem Daro) capsule two times daily for 10 days. Intervention 2: Control group: 750 mg placebo (Ghaem Daro) capsule two times daily for 10 days.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18-65 years Having cold or influenza according to internist diagnosis Willing to participate in the study

Exclusion criteria

Exclusion criteria: Using antibiotic Having diabetes Having known cardiovascular diseases Having known renal diseases Having any types of cancer Pregnancy Lactation

Design outcomes

Primary

Measure	Time frame
Rhinorrhea and nasal congestion severity. Timepoint: Baseline and at the end of the study. Method of measurement: Visual analog scale (10 score).;Cough severity. Timepoint: Baseline and at the end of the study. Method of measurement: Visual analog scale (10 score).;Sneeze severity. Timepoint: Baseline and at the end of the study. Method of measurement: Visual analog scale (10 score).;Disease duration. Timepoint: At the end of the study. Method of measurement: Questioning.	—

Measure

Time frame

Rhinorrhea and nasal congestion severity. Timepoint: Baseline and at the end of the study. Method of measurement: Visual analog scale (10 score).;Cough severity. Timepoint: Baseline and at the end of the study. Method of measurement: Visual analog scale (10 score).;Sneeze severity. Timepoint: Baseline and at the end of the study. Method of measurement: Visual analog scale (10 score).;Disease duration. Timepoint: At the end of the study. Method of measurement: Questioning.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoodeh Razghei Jahromi

Shahid Beheshti University of Medical Sciences

soodehrazeghi@gmail.com+98 21 2235 7483

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026